443 related articles for article (PubMed ID: 19098997)
1. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.
Mas VR; Maluf DG; Archer KJ; Yanek K; Kong X; Kulik L; Freise CE; Olthoff KM; Ghobrial RM; McIver P; Fisher R
Mol Med; 2009; 15(3-4):85-94. PubMed ID: 19098997
[TBL] [Abstract][Full Text] [Related]
2. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.
De Giorgi V; Buonaguro L; Worschech A; Tornesello ML; Izzo F; Marincola FM; Wang E; Buonaguro FM
PLoS One; 2013; 8(2):e56153. PubMed ID: 23441164
[TBL] [Abstract][Full Text] [Related]
3. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
4. Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma.
Zheng S; Tansey WP; Hiebert SW; Zhao Z
BMC Med Genomics; 2011 Aug; 4():62. PubMed ID: 21824427
[TBL] [Abstract][Full Text] [Related]
5. Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.
De Giorgi V; Monaco A; Worchech A; Tornesello M; Izzo F; Buonaguro L; Marincola FM; Wang E; Buonaguro FM
J Transl Med; 2009 Oct; 7():85. PubMed ID: 19821982
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
[TBL] [Abstract][Full Text] [Related]
7. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
8. Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Diaz G; Engle RE; Tice A; Melis M; Montenegro S; Rodriguez-Canales J; Hanson J; Emmert-Buck MR; Bock KW; Moore IN; Zamboni F; Govindarajan S; Kleiner DE; Farci P
Mol Cancer Res; 2018 Sep; 16(9):1406-1419. PubMed ID: 29858376
[TBL] [Abstract][Full Text] [Related]
9. Differentially expressed genes between early and advanced hepatocellular carcinoma (HCC) as a potential tool for selecting liver transplant recipients.
Mas VR; Maluf DG; Archer KJ; Yanek K; Williams B; Fisher RA
Mol Med; 2006; 12(4-6):97-104. PubMed ID: 16953559
[TBL] [Abstract][Full Text] [Related]
10. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity.
Dillon ST; Bhasin MK; Feng X; Koh DW; Daoud SS
J Transl Med; 2013 Oct; 11():239. PubMed ID: 24283668
[TBL] [Abstract][Full Text] [Related]
12. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.
Iizuka N; Oka M; Yamada-Okabe H; Hamada K; Nakayama H; Mori N; Tamesa T; Okada T; Takemoto N; Matoba K; Takashima M; Sakamoto K; Tangoku A; Miyamoto T; Uchimura S; Hamamoto Y
Int J Oncol; 2004 Mar; 24(3):565-74. PubMed ID: 14767541
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesis.
Hass HG; Jobst J; Vogel U; Scheurlen M; Nehls O
Oncol Res Treat; 2014; 37(12):732-8. PubMed ID: 25531719
[TBL] [Abstract][Full Text] [Related]
15. The role of Hepatitis C Virus in the dynamic protein interaction networks of hepatocellular cirrhosis and carcinoma.
Huang T; Liu L; Liu Q; Ding G; Tan Y; Tu Z; Li Y; Dai H; Xie L
Int J Comput Biol Drug Des; 2011; 4(1):5-18. PubMed ID: 21330691
[TBL] [Abstract][Full Text] [Related]
16. Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma.
Lee CF; Ling ZQ; Zhao T; Lee KR
World J Gastroenterol; 2008 Oct; 14(39):6072-7. PubMed ID: 18932288
[TBL] [Abstract][Full Text] [Related]
17. Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus.
Zekri AR; Hassan ZK; Bahnassy AA; Sherif GM; ELdahshan D; Abouelhoda M; Ali A; Hafez MM
Asian Pac J Cancer Prev; 2012; 13(11):5433-8. PubMed ID: 23317196
[TBL] [Abstract][Full Text] [Related]
18. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
[TBL] [Abstract][Full Text] [Related]
19. From cirrhosis to hepatocellular carcinoma in HCV-infected patients: genes involved in tumor progression.
Wang Y; Li J; Chen J; Liu L; Peng Z; Ding J; Ding K
Eur Rev Med Pharmacol Sci; 2012 Aug; 16(8):995-1000. PubMed ID: 22913147
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiles of HCV cirrhotic tissues derived in a panel of markers with clinical utility for hepatocellular carcinoma surveillance.
Gehrau RC; Archer KJ; Mas VR; Maluf DG
PLoS One; 2012; 7(7):e40275. PubMed ID: 22792259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
